Online Program
Return to main conference page
All Times EDT
Friday, September 25
Fri, Sep 25, 3:30 PM - 4:45 PM
Virtual
Challenges and Recommendations in Using Biomarker/Surrogate Endpoints for the Accelerated Approval
Peter Mesenbrink's Discussion (302312)
View Video
*
Peter Mesenbrink, Novartis
↑